Affordable Pricing for Taxpayer-Funded Prescription Drugs Act of 2026
See how your representatives voted on this bill.
DeepSyte matches this bill to the issues you care about and shows whether your reps' votes line up — not party, not press releases. Take the 2-minute values quiz to see your alignment.
Alignment with your views
Sign in and take the values quiz to see how this bill lines up with what you've said.
Summary
This bill requires federal agencies to include reasonable pricing agreements in all research funding arrangements and intellectual property licenses for biomedical products developed with federal funds. Reasonable pricing is defined to ensure U.S. residents do not pay more than the median price charged in Canada and six other high-income OECD countries. The Secretary of Health and Human Services may establish additional pricing requirements, grant waivers in the public interest, and require manufacturers to report development costs, federal subsidies, and annual revenues.
Values analysis
Sign in and take the values quiz to get a personalized read on how this bill lines up with your positions.
How your representatives voted
Sign in to see how your representatives voted on this bill.